InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,319.31
(
2.30%
)
US TECH 100
18,052.00
(
0.72%
)
Dow Jones
39,446.49
(
1.76%
)
Brent Oil
78.83
(
0.11%
)
Bitcoin
60,920.21
(
-1.32%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

kei

Send PM Follow Ignore
Followers 306
Posts 22916
Boards Moderated 0
Alias Born 10/10/2007

kei

Re: kei post# 96181

Saturday, 01/28/2017 10:02:38 AM

Saturday, January 28, 2017 10:02:38 AM

Post# of 97239
SGYP..

its great to know that tute(s) are buying more and more.
Blackrock increases position by 90%, become 2nd largest tute at 15,871,299 shares (8.8%), from 8,314,627 shares. http://secfilings.nasdaq.com/filingFrameset.asp?FilingID=11803589&RcvdDate=1/27/2017&CoName=SYNERGY%20PHARMACEUTICALS%2C%20INC.&FormType=SC%2013G/A&View=html …

SGYP owns 100% worldwide rights to its proprietary uroguanylin analog platform that includes two lead product candidates – plecanatide and dolcanatide...imo, many people underestimate its value.

this is imo only but this filing last month shows clearly they want to sell the company: http://ih.advfn.com/p.php?pid=nmona&article=73518126



°°° (\__/) (\_(\ ° ° °
°°° (='.'=) (=' :') °°°
°°° (")_(") (,(')(')°°°
°°° °°° °°° °°° °°°


Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up